SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
James Paton
Page 2 of 3
Health
How vaccine nationalism could extend the pandemic
By
James Paton
and
Bloomberg
Health
Public health officials warn about slow vaccine rollout as coronavirus variants multiply
By
James Paton
and
Bloomberg
Health
Drugmakers hit back at U.K. plan to delay the second dose of COVID vaccines
By
James Paton
and
Bloomberg
Health
AstraZeneca acquires rare-disease specialist Alexion in $39 billion deal
By
John Lauerman
,
James Paton
, and others
International
Britons will roll up their sleeves on Tuesday for a COVID vaccine jab as the world anxiously watches
By
James Paton
,
Suzi Ring
, and others
International
U.K. approves Pfizer COVID-19 vaccine and will start distributing it next week
By
James Paton
and
Bloomberg
Health
AstraZeneca eyes another global trial for its COVID vaccine following dosage blip
By
Suzi Ring
,
James Paton
, and others
Health
Oxford says COVID-19 vaccine has produced strong immune response ahead of late-stage trial results
By
James Paton
,
Suzi Ring
, and others
Health
AstraZeneca-Oxford COVID vaccine on track for year end, CEO Pascal Soriot says
By
Suzi Ring
,
James Paton
, and others
International
To jumpstart the COVID vaccine race, the U.K. considers ‘challenge trials’ exposing people to the virus
By
James Paton
and
Bloomberg
Health
Weight loss and obesity drugs could help fight COVID-19, Novo Nordisk says
By
James Paton
and
Bloomberg
International
These countries aren’t waiting for a U.S., China, or U.K. COVID vaccine
By
James Paton
and
Bloomberg
Health
U.S. pledges $2.1 billion for up to 600 million doses of Sanofi, GlaxoSmithKline vaccine
By
James Paton
and
Bloomberg
International
The earliest coronavirus vaccines may not protect you from getting infected
By
John Lauerman
,
James Paton
, and others
International
France’s Sanofi to sell stake in high-flying Regeneron to fund new drugs discoveries
By
James Paton
,
Riley Griffin
, and others